# clm_B41FB990A838

subject: Abbott Laboratories (/record/abbott-laboratories.md)  
predicate: quarterly_operating_income  
value: 1,647,000,000 United States dollar  
valid_from: 2023-09-30  
valid_to: 2024-03-31  
published: 2023-11-01  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_FDE13F28F4C1  
last_updated: 2026-11-08  
cite: AsOf. "Abbott Laboratories quarterly operating income: 1,647,000,000 United States dollar", as of 2023-09-30 (until 2024-03-31). Claim clm_B41FB990A838, https://asof.is/claim/clm_B41FB990A838, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1800/000162828023035957/0001628280-23-035957-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2023, filed 2023-11-01  

## Sources

- https://www.sec.gov/Archives/edgar/data/1800/000162828023035957/0001628280-23-035957-index.htm (primary, SEC EDGAR 10-Q Q3 FY2023, published 2023-11-01)

## Supersedes

- [Abbott Laboratories](/record/abbott-laboratories.md) | quarterly_operating_income | 1,542,000,000 United States dollar | valid 2023-06-30 to 2023-09-30 | conf 0.95 | superseded | superseded_by [clm_B41FB990A838](/claim/clm_B41FB990A838.md) | [clm_2E82AF12DD3E](/claim/clm_2E82AF12DD3E.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.